Saturday 17 October 2026 Export TAK’s income statement to Excel — free account

Takeda Pharmaceutical Co.

TAK Healthcare Drug Manufacturers Specialty & Generic

Takeda Pharmaceutical Co.’s revenue for fiscal 2026 (year ended March 2026) was $29.7 billion, down 1.66% from fiscal 2025. In the quarter to June 2026, revenue grew 1.71%, EPS fell 4.35%, free cash flow fell 95.6% and total debt fell 2.58%, each against the same quarter a year earlier.

19.67 0.22 +1.13%

Follow TAK

Alert me

Market cap: $61.9B
P/E: 29.6×
Fwd P/E: —
Dividend yield: 1.57%
F-score: 4/9
Altman Z: 1.03
Beneish M: −2.65
Dividend safety: 25/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Dec '25	Sep '25	Jun '25	Older periods
Piotroski F-Score Full definition →	6	—	—	7	+8 more TTM periods Free account
ROE Full definition →	4.42%	0.00%	0.00%	4.39%
ROA Full definition →	2.15%	0.00%	0.00%	2.13%
ROIC Full definition →	2.88%	0.00%	0.00%	2.42%
Return on Tangible Assets Full definition →	13.40%	0.00%	0.00%	13.48%
Average Days of Receivables Full definition →	73.31	0.00	0.00	57.31
Free Cash Flow per Share Full definition →	2.35	0.00	0.00	2.02
Free Cash Flow Full definition →	7,420.86	10,878.22	8,314.41	6,324.44
Capital Expenditures Full definition →	(3,704.87)	(4,954.63)	(3,167.12)	(3,696.62)
Other line items
Cash ROIC Full definition →	9.04%	12.62%	9.77%	7.77%
Accounts Receivable Turnover Full definition →	5.52	0.00	0.00	6.29
Accounts Payable Turnover Full definition →	3.50	0.00	0.00	3.07
Inventory Turnover Full definition →	1.18	0.00	0.00	1.21
Average Days of Payables Full definition →	100.31	0.00	0.00	103.42
Days of Inventory on Hand Full definition →	324.95	0.00	0.00	304.55
Tax Rate Full definition →	(0.17)	—	—	0.10
Research and Development Expense of Revenue Full definition →	14.77%	—	—	15.57%
Selling, General and Administrative Expense of Revenue Full definition →	23.99%	—	—	24.14%
Share Based Compensation of Revenue Full definition →	2.33%	0.00%	0.00%	2.43%
Interest Coverage Full definition →	1.99	—	—	1.62
Operating CF/Net income Full definition →	5.21	0.00	0.00	4.68
Depreciation/Fixed assets Full definition →	0.53	0.73	0.56	0.56
Capex/Depreciation Full definition →	(0.52)	(0.50)	(0.42)	(0.49)
Revenue per Share Full definition →	9.49	—	—	9.54
Operating CF per Share Full definition →	3.52	0.00	0.00	3.20
Capex per Share Full definition →	(1.17)	0.00	0.00	(1.18)
Capex to Sales Full definition →	0.12	0.00	0.00	0.12

Show all line items

Columns are period end dates

Stockrow Weekly